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Childhood systemic lupus erythematosus Boon SJ. Pediatric Annals 2002; 31:407 OBJECTIVE: To review epidemiology, pathophysiology, evaluation, diagnosis and management of systemic lupus erythematosus (SLE) in children.
BACKGROUND: SLE is less common in children than adults; often presenting at puberty, with approximately 25% of cases beginning before age 20. It is important to recognize this disease early, because, while it may be episodic and indolent, it appears to be more severe in children than adults. It can rapidly become life-threatening without appropriate treatment.
FINDINGS: SLE occurs in all ethnic groups, but is more frequent and severe in Americans of African, Latino, and Asian descent than in those of European descent. It is seen more often in females, with a ratio of 5 to 10:1.2. Etiology is not well understood. Genetic predisposition, immune system dysregulation, environmental stimuli, and hormonal factors have all been associated with the disease. Pathologic mechanisms are better understood. Most patients have autoantibodies directed against nuclear and cytoplasmic self-antigens. Organ-specific antibodies to cell surface antigens, particularly against blood, skin, and thyroid antigens, are also present. The diagnostic criteria for SLE revised in 1982, requiring that 4 of 11 clinical symptoms or laboratory criteria be met, were later modified in 1997 to include antiphospholipid antibodies as part of the immunoserology. Patients with SLE often have 6 or more autoantibodies. The most common are antibodies to nuclear double-stranded DNA, and approximately a third of patients additionally have antiphospholipid antibodies associated with thrombotic events. Renal disease affects 50-90% of children, with frequent morbidity and mortality. The course follows a remitting-relapsing pattern, but the 5-year outcome for children with SLE has improved markedly over the past 40 years.
CONCLUSION:
Patients with moderate to severe SLE should be regularly observed by a pediatric rheumatologist, to monitor clinical status and laboratory results. It is also necessary that they maintain a close relationship with their primary care physician for routine care and to treat minor infections. 3. Pediatric Dermatology DOI: 10.1007 DOI: 10. /s10227-003-2003 Sebaceus naevi: a clinicopathologic study Muñ oz-Pérez MA. JEADV 2002; 16:319-324 OBJECTIVE: To review cases of excised sebaceous nevus (SN) to determine the incidence of associated malignancies and developmental defects.
BACKGROUND AND METHODS: SN is a common congenital hamartoma. It commonly presents sebaceous differentiation (but epithelial, trichelemmal or aprocrine differentiation have also observed). SN is found in about 0.3% of all neonates, but may occasionally appear later in life. Diagnosis is usually made before age 40. Prophylactic surgery has been usually recommended because the development of various carcinomas on SN has been reported. BCC has been the malignant tumor most frequently found, but squamous cell, sebaceous, and apocrine carcinomas have also been reported. Locally aggressive or metastatic carcinomas are rare and the benefit of systematic prophylactic surgery is open to question. The histopathologic and clinical information from 226 cases of SN excised from 1979 to 1999 was reviewed. All cases of epidermal nevus syndrome (Schimmelpenning syndrome) associated with SN were noted, as well as all patients with histological changes indicative of degeneration of the initial SN.
RESULTS:
Patients with SN were 0.8% of all dermatological patients seen during the study years. The incidence of SN was comparable between the sexes and the majority of patients were between the ages of 10 and 30 years. Stage II nevi (verrucous-papillomatous plaque stage) were most common, observed in 65% of cases, with 42% of SN located in the parietal area and only 7% located in non-scalp areas. The most common tumors arising on SN were syringocystadenoma papilliferum and trichoblastoma. Only 8 patients (3.5%) were found with basal cell carcinoma arising from previous SN. Epidermal nevus syndrome was the most common neurocutaneous manifestation, diagnosed in 16 patients.
CONCLUSION: There was a very low incidence of malignancy arising from SN, indicating that prophylactic surgery in children should not necessarily be indicated. However, the investigation of developmental defects is recommended in order to identify possible epidermal nevus syndrome associated with SN.
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Childhood lichen planus: a study of 87 cases Handa S, Sahoo B. Int J Dermatol 2002; 41:423-427 This study analyzed the clinical profile of childhood lichen planus (LP) prevailing in north India, highlighting differences and similarities with adult LP. Eighty-seven children with LP (46 boys, 41 girls) were examined during a 12.5-year period of observation. The age at onset was between 8 months and 12 years (mean, 7.1 years). Classical LP was observed in 53 patients (60.9%), followed by actinic LP in 10 (11.5%) and lichen planus hypertrophicus (LPH) and linear LP in eight each (9.2%). Other forms seen were eruptive, follicular, lichen planopilaris, atrophic, and bullous LP. The involvement of skin alone was seen in 75 children (86.2%) and mucosa alone in one child (1.1%). The authors conclude that the natural history of LP in children is essentially similar to that in adults.
Congenital melanocytic nevi: an update for the pediatrician Makkar HS, Frieden IJ. Curr Opin Pediatr 2002; 14:397-403 This article discusses congenital nevi, one of several known risk factors for the development of melanoma. This risk appears to be greatest during early childhood. Large congenital nevi, particularly those overlying the head and neck, may also be associated with neurocutaneous melanosis. Symptomatic neurocutaneous melanosis, although rare, carries a poor prognosis, while asymptomatic neurocutaneous melanosis may be more common than previously recognized. Large congenital nevi are usually treated with primary excisions and closures, assisted by tissue-expansion techniques and skin grafting. Until the associated risks are better defined, therapy of small congenital nevi should be individualized, with consideration given to additional melanoma risk factors.
